First Time Loading...
Z

Zomedica Corp
NYSE-MKT:ZOM

Watchlist Manager
Zomedica Corp
NYSE-MKT:ZOM
Watchlist
Price: 0.1452 USD 2.25% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

ZOM Price Targets Summary
Zomedica Corp

Wall Street analysts forecast ZOM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZOM is 0.44 USD .

ZOM Lowest Forecast
Wall Street Target
Not Available
ZOM Average Forecast
Wall Street Target
0.44 USD
203% Upside
ZOM Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
0.44 USD
203% Upside
Highest
Price Target
Not Available
Zomedica Corp Competitors:
Price Targets
METN
Metall Zug AG
59% Upside
I
ITGR
Integer Holdings Corp
16% Upside
LMAT
LeMaitre Vascular Inc
2% Downside
CODX
Co-Diagnostics Inc
111% Upside
METN
Metall Zug AG
59% Upside
I
ITGR
Integer Holdings Corp
16% Upside
LMAT
LeMaitre Vascular Inc
2% Downside
CODX
Co-Diagnostics Inc
111% Upside
300482
Guangzhou Wondfo Biotech Co Ltd
31% Upside
ECOR
electroCore, Inc.
273% Upside
SN
Smith & Nephew PLC
32% Upside
GN
GN Store Nord A/S
9% Upside

Revenue
Forecast

Revenue Estimate
Zomedica Corp

The compound annual growth rate of Zomedica Corp's revenue for the next 3 years is 26%.

N/A
Past Growth
26%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Zomedica Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Zomedica Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
What are analyst estimates?

See Also

Summary
ZOM intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZOM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZOM stock valuation using valuation multiples.
Wall Street Estimates
ZOM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZOM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZOM's stock price target?
Price Target
0.44 USD

According to Wall Street analysts, the average 1-year price target for ZOM is 0.44 USD .

What is Zomedica Corp's Revenue forecast?
Projected CAGR
26%

The compound annual growth rate of Zomedica Corp's revenue for the next 3 years is 26%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.